Adherence to PARP inhibitor therapy among women with ovarian cancer
Haley Moss, Ling Chen, Dawn L. Hershman, Brittany A. Davidson, Jason D. Wright
Topics & Concepts
MedicineInternal medicineOvarian cancerPARP inhibitorLogistic regressionOncologyCancerPopulationPsychological interventionGynecologyPoly ADP ribose polymeraseGeneBiochemistryEnvironmental healthPsychiatryChemistryPolymeraseMedication Adherence and CompliancePARP inhibition in cancer therapyEconomic and Financial Impacts of Cancer